ProDHA 1000 (Docosahexaenoic Acid)

ProDHA 1000 is a concentrated docosahexaenoic acid (DHA) supplement providing 1000mg of this omega-3 fatty acid per serving. DHA supports brain health by maintaining neuronal membrane fluidity and reducing neuroinflammation through specialized pro-resolving mediators.

Origin & History

ProDHA 1000 is a branded supplement providing 1000 mg of docosahexaenoic acid (DHA), a long-chain omega-3 fatty acid typically sourced from marine algae or fish oil. DHA is extracted via supercritical CO2 or molecular distillation to purify and concentrate the oil, yielding standardized forms such as triglyceride or ethyl ester.

Historical & Cultural Context

No traditional medicine context for ProDHA 1000 or branded DHA was found in the research. DHA's dietary sources (fatty fish) have been part of coastal diets historically for heart and brain health, but lack formalization in traditional medicine systems.

Health Benefits

• May improve depression symptoms in patients with baseline inflammation - one RCT (n=30) showed responders had higher CRP reductions (PMID: 26099251) [Moderate evidence]
• Potential neuroprotective effects in traumatic brain injury when combined with progesterone therapy (PMID: 24717925) [Preliminary evidence]
• May modulate brain development through influence on Bdnf gene methylation (PMID: 27302179) [Preliminary evidence]
• General omega-3 benefits for brain health at 500-2000 mg/day doses [Limited specific evidence for ProDHA 1000]
• Anti-inflammatory properties through generation of resolvins and protectins via GPR120 receptors [Mechanism-based evidence only]

How It Works

DHA incorporates into neuronal phospholipid membranes, particularly phosphatidylserine and phosphatidylethanolamine, enhancing membrane fluidity and synaptic function. It serves as a precursor to specialized pro-resolving mediators like resolvins and protectins, which resolve neuroinflammation. DHA also modulates BDNF expression and supports mitochondrial function in neural tissues.

Scientific Research

Limited clinical evidence exists specifically for ProDHA 1000. Available research includes an RCT (n=30) showing omega-3 fatty acids including DHA improved major depressive disorder symptoms moderated by baseline inflammation (PMID: 26099251). Another study suggested DHA enhanced progesterone's neuroprotection in traumatic brain injury (PMID: 24717925).

Clinical Summary

One randomized controlled trial (n=30) demonstrated that DHA supplementation improved depression symptoms specifically in patients with baseline inflammation, with responders showing greater C-reactive protein reductions. Preliminary evidence suggests potential neuroprotective effects when combined with progesterone therapy for traumatic brain injury. The current evidence base is limited, with small sample sizes and few high-quality studies available for most claimed benefits.

Nutritional Profile

ProDHA 1000 is a concentrated docosahexaenoic acid (DHA) supplement, typically providing ~1000 mg DHA per serving (usually 2 softgels), derived from molecularly distilled fish oil (commonly anchovy and sardine sources). Each serving typically also contains approximately 200–250 mg eicosapentaenoic acid (EPA) as a secondary omega-3 fatty acid, with total omega-3 content around 1250–1300 mg per serving. The supplement is delivered in a triglyceride (TG) form, which has approximately 70% higher bioavailability compared to the ethyl ester (EE) form commonly found in cheaper fish oil products (PMID: 21854650). DHA (C22:6, n-3) is the primary bioactive compound — a 22-carbon polyunsaturated fatty acid with 6 double bonds that is a major structural component of neuronal cell membranes, comprising ~40% of polyunsaturated fatty acids in brain gray matter and ~60% in retinal photoreceptor outer segments. Caloric content is approximately 10–15 kcal per serving from fat. Typically contains added vitamin E (as d-alpha tocopherol, ~10–20 IU) as an antioxidant to prevent lipid peroxidation. No significant protein, carbohydrate, fiber, or mineral content. Key bioactive metabolites of DHA include resolvins (D-series: RvD1, RvD2), protectins (neuroprotectin D1/NPD1), and maresins, which are specialized pro-resolving mediators (SPMs) with potent anti-inflammatory and neuroprotective properties. DHA is preferentially incorporated into membrane phospholipids (phosphatidylethanolamine and phosphatidylserine), where it modulates membrane fluidity, lipid raft organization, and receptor signaling. Absorption is enhanced when taken with a fat-containing meal (bioavailability increases ~3-fold compared to fasting state). Peak plasma DHA levels occur approximately 5–6 hours post-ingestion, with steady-state tissue incorporation requiring 4–8 weeks of consistent supplementation. The high DHA-to-EPA ratio (~4:1 to 5:1) distinguishes this formulation from standard fish oils (~1:1.5 DHA:EPA) and makes it particularly suited for neurological and neurodevelopmental applications.

Preparation & Dosage

No clinically studied dosages specific to ProDHA 1000 appear in available research. General DHA studies use 500-2000 mg/day in triglyceride form for brain health or inflammation. The product delivers 1000 mg DHA per serving. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

EPA, Vitamin E, Phosphatidylserine, Astaxanthin, Vitamin D3

Safety & Interactions

DHA supplements are generally well-tolerated with mild gastrointestinal side effects possible at higher doses. They may increase bleeding risk when combined with anticoagulant medications like warfarin due to mild antiplatelet effects. Pregnant and breastfeeding women should consult healthcare providers before supplementing, though DHA is considered safe during pregnancy. Quality concerns exist with some fish oil products regarding heavy metal contamination and oxidation.